slno,preds
0,"## Answer

(model generated chain of thought explanation)

The patient has pancreatic adenocarcinoma, and the pathology report provides detailed information about the tumor's histology, size, extent of invasion, lymphatic invasion, venous invasion, perineural invasion, and surgical margins.

First, I will analyze the tumor's histology and grade. The tumor is moderately differentiated adenocarcinoma, which is an intermediate-grade tumor.

Next, I will evaluate the tumor's size and extent of invasion. The tumor measures 4.5 cm in diameter, and it has invaded the peripancreatic soft tissues, duodenum, and ampulla wall. This suggests that the tumor has invaded beyond the pancreas and has spread to adjacent structures.

The report also mentions that the tumor has not invaded the lymphatic vessels, veins, or nerves. However, metastatic carcinoma is identified in two lymph nodes, which indicates that the tumor has spread to regional lymph nodes.

The surgical margins are also important in determining the stage of the tumor. The report states that the surgical margins are negative, except for the peripancreatic soft tissues, which are focally close to the inked margin.

Based on the above information, I conclude that the patient has Stage III pancreatic cancer. The tumor has invaded beyond the pancreas and has spread to adjacent structures, and it has also metastasized to regional lymph nodes.

Therefore, the answer is:

{""stage"" : Stage III}"
1,"## Question: Can you identify the AJCC Stage of the Cancer from the following Pathology Report?

Pancreatic ductal adenocarcinoma, moderately differentiated. - AJCC pathologic stage (7th edition): pT3 pN1, stage IIB.

## Model generated chain of thought explanation

The pathology report provides the AJCC pathologic stage as pT3 pN1, stage IIB. The T stage (pT) indicates that the tumor has invaded peripancreatic soft tissues, which corresponds to pT3. The N stage (pN) indicates that there is regional lymph node involvement, specifically 1 out of 23 lymph nodes examined, which corresponds to pN1.

The AJCC staging system for pancreatic cancer is based on the TNM system, which takes into account the tumor size (T), lymph node involvement (N), and distant metastasis (M). For pancreatic cancer, the staging system is as follows:

* T1: Tumor is limited to the pancreas and is less than 2 cm in diameter.
* T2: Tumor is limited to the pancreas and is 2-4 cm in diameter.
* T3: Tumor has invaded peripancreatic soft tissues.
* T4: Tumor has invaded adjacent organs or structures.
* N0: No regional lymph node involvement.
* N1: Regional lymph node involvement.
* M0: No distant metastasis.
* M1: Distant metastasis.

Based on the pathology report, the tumor has invaded peripancreatic soft tissues (pT3) and there is regional lymph node involvement (pN1). Therefore, the AJCC stage is stage IIB.

## Answer
{""stage"" : ""Stage IIB""}"
2,"## Answer

(model generated chain of thought explanation)

The patient has pancreatic duct carcinoma, which is a type of pancreatic cancer. The pathology report indicates that the tumor is moderately to poorly differentiated, invasive, and has invaded into peripancreatic adipose tissue, duodenal wall, and ulcerated the duodenal mucosa. The tumor size is approximately 6.0 cm, and it has extended beyond the pancreas into peripancreatic tissue and the zone between the pancreas and duodenum.

The report also mentions that the tumor has invaded into the muscularis propria of the duodenum, ulcerated the overlying duodenal mucosa, and focally involved the uncinate margin. Additionally, there is prominent perineural invasion, lymphovascular invasion, and metastatic carcinoma in four of eleven lymph nodes.

Based on these findings, the patient's cancer stage is likely to be Stage III. The tumor has invaded into surrounding tissues and organs, and there is evidence of lymph node metastasis, which are both characteristic features of Stage III pancreatic cancer.

Therefore, the answer is - 
{""stage"" : Stage III}"
3,"## Question: Can you identify the AJCC Stage of the Cancer from the following Pathology Report?

Gross Description: Whipple, FS: Received is a Whipple specimen consisting of duodenum and pancreas. The duodenum measures 19 cm in length X 2.5-3.5 cm in diameter. Both ends are stapled closed. The. serosa is smooth, tan-pink, and the stapled margins are inked black. The duodenum is opened and. reveals a stent in the ampulla and a 1.5 X 1-cm area of flattened mucosa with underlying palpable,. indurated mass 3 cm proximal to the ampulla. The proximal duodenal margin is removed entirely en. face and used for frozen section diagnosis and is resubmitted in toto. The pancreas measures 5.8 X 4 x 4. cm. The neck margin is inked blue, and the radial margin is inked black. On sectioning, a 4 X 3.8 x 3-cm,. ill-defined, indurated, white-yellow mass with clear tan, mucinous filled cystic spaces is identified in the. head of the pancreas, 0.6 cm to the neck. margin, approximately 0.2 the ampulla, and focally abuts the Adenocareenina, deatnos. cm to. black-inked radial margin, and grossly extends to the proximal duodenal Site Vancreas head. margin. The ill-defined mass surrounds the main pancreatic and common bile ducts;. however, both ducts are probe patent through the ampulla. The common bile. duct contains a blue stent. The ducts appear to enter the duodenum via. adjacent but separate ductal ampullae. Common bile duct at the margin is. dilated at 1 cm in diameter. The main pancreatic duct at the neck margin. is dilated up to 0.6 cm in diameter. Sectioning through the mass into the duodenum proximal to the ampulla. reveals the mass to extend grossly into the muscularis of the duodenum and. a clear, mucinous, fluid-filled space, 1.4 cm in greatest dimension,. subjacent to the flattened duodenal mucosal area. Sectioning and palpation of the peripancreatic fat reveals"
4,"## Model-generated chain of thought explanation

First, I will analyze the pathology report to identify the key features of the tumor. The tumor is a ductal adenocarcinoma, moderately differentiated, with a size of approximately 3.0 cm. The tumor is located in the head of the pancreas and has invaded the ampulla of Vater, but there is no perineural or angiolymphatic invasion.

Next, I will examine the margins of the tumor. The tumor is negative for malignancy at the common bile duct, pancreatic duct, soft tissue, retroperitoneal margin, and pancreatic resection margin. This suggests that the tumor has not invaded these structures.

The lymph nodes are also negative for malignancy, with 12 lymph nodes examined. This suggests that the tumor has not metastasized to the lymph nodes.

Based on the pathology report, I can conclude that the tumor is limited to the pancreas and has not invaded any surrounding structures or metastasized to the lymph nodes. This is consistent with a Stage I or Stage II tumor.

However, the tumor has invaded the ampulla of Vater, which is a major criterion for staging pancreatic cancer. According to the AJCC staging system, a tumor that invades the ampulla of Vater is considered to be at least T3, which is a criterion for Stage III.

Therefore, based on the pathology report, I conclude that the patient has Stage III pancreatic cancer.

## Answer
{""stage"" : Stage III}"
5,"## Question: Can you identify the AJCC Stage of the Cancer from the following Pathology Report?

pT3 N1 (7th edition)

## Model-generated chain of thought explanation:

The pathology report provides information about the tumor's size, location, and extent of invasion, as well as the presence of lymph node metastasis. The report states that the tumor is 2.8 cm in greatest dimension, located in the uncinate process, and extends beyond the pancreas to involve peripancreatic soft tissue, duodenal wall, and superior mesenteric vein. Angiolymphatic and perineural invasion are also present.

The report also states that multiple (2 of 19) lymph nodes are involved by metastatic carcinoma, indicating lymph node metastasis.

Based on the 7th edition AJCC staging system, the tumor is classified as pT3 (T3: Tumor extends beyond the pancreas to involve peripancreatic soft tissue, duodenal wall, and superior mesenteric vein) and N1 (N1: Metastasis in 1-3 lymph nodes).

Therefore, the AJCC stage is Stage III.

## Answer:
{""stage"" : Stage III}"
6,"## Answer

(model generated chain of thought explanation)

The patient has been diagnosed with invasive ductal adenocarcinoma, moderately differentiated, with a tumor size of 3.0 cm. The tumor invades the duodenal wall, peripancreatic soft tissues, and extrapancreatic common bile duct, and also invades the middle celiac vein. The tumor is positive for metastatic adenocarcinoma in the middle celiac vein biopsy.

The pathologic stage is pT4NO, indicating that the tumor has invaded the celiac axis or the superior mesenteric artery, and there is no regional lymph node metastasis.

Based on the AJCC staging system, the patient's tumor is classified as T4, which corresponds to Stage III.

Therefore, the answer is:

{""stage"" : Stage III}"
7,"## Answer

(model generated chain of thought explanation)

First, I will analyze the TNM classification provided in the pathology report: pT3, pN1 (3/43), L1, Pn1. 

* pT3 indicates that the tumor has penetrated through the pancreatic head and infiltrated the peripancreatic fatty tissue, which is a characteristic of T3 stage.
* pN1 indicates that there are 1-3 positive lymph nodes, which is also consistent with N1 stage.
* L1 and Pn1 indicate that there is no distant metastasis and no peritoneal metastasis, respectively.

Next, I will consider the grading: G3, which indicates that the tumor is moderately to poorly differentiated, which is consistent with a higher stage.

Given the T3 and N1 stages, and the G3 grading, I conclude that the patient has Stage III cancer.

Therefore, the answer is - 
{""stage"" : Stage III}"
8,"## Question: Can you identify the AJCC Stage of the Cancer from the following Pathology Report?

(A) Stage I 
(B) Stage II 
(C) Stage III 
(D) Stage IV

## Model-generated chain of thought explanation:

First, I will identify the tumor characteristics from the pathology report:

* Tumor size: 5.0 cm
* Tumor location: Pancreatic body
* Tumor type: Invasive moderately differentiated ductal adenocarcinoma
* Tumor grade: Moderately differentiated
* Lymphovascular invasion: Absent
* Perineural invasion: Absent
* Tumor necrosis: Absent
* Surgical margins: All negative for tumor (minimum tumor-free margin, 2.5 cm, pancreatic neck margin)

Next, I will evaluate the lymph node status:

* Number of regional lymph nodes: 16
* Lymph node status: All negative for metastatic tumor

Based on the AJCC 7th edition (2010) staging criteria, I will determine the stage:

* T stage: T3 (tumor size > 4 cm, but not > 5 cm, and extends beyond pancreas)
* N stage: N0 (no regional lymph node metastasis)
* M stage: M0 (no distant metastasis)

Therefore, the AJCC stage is T3 N0 M0, which corresponds to Stage III.

## Answer:
{""stage"" : Stage III}"
9,"## Model-generated chain of thought explanation

The pathology report indicates that the patient has invasive grade 3 (of 4) ductal adenocarcinoma in the pancreatic head, which is a high-grade tumor. The tumor is 3.3 x 3.2 x 2.6 cm in size and extends beyond the pancreas, involving the peripancreatic soft tissue and duodenal submucosa. The tumor also involves the ampulla and surrounding soft tissue.

The report states that the tumor is T3, as it extends beyond the pancreas, and N1, as there are multiple regional lymph nodes positive for metastatic adenocarcinoma. The report also mentions that the tumor is AJCC pT3N1 (7th edition, 2010).

Based on the TNM staging system, the T3 stage indicates that the tumor has penetrated the pancreatic capsule and/or adjacent structures, and the N1 stage indicates that there is regional lymph node involvement. Therefore, the patient has Stage III cancer.

## Answer
{""stage"" : Stage III}"
10,"## Question: Can you identify the AJCC Stage of the Cancer from the following Pathology Report?

(A) Stage I 
(B) Stage II 
(C) Stage III 
(D) Stage IV

## Model-generated chain of thought explanation:

First, I will identify the type of cancer based on the pathology report. The report states that the diagnosis is adenocarcinoma, which is a type of cancer that originates in the glandular tissue of the pancreas.

Next, I will assess the tumor size and location. The report states that the tumor measures about 4.5 cm in greatest dimension and is located in the head of the pancreas. This suggests that the tumor is relatively large and has invaded the surrounding tissue.

The report also states that the tumor has invaded the common bile duct and the muscular wall of the duodenum, which are both considered to be regional lymph nodes. This suggests that the tumor has spread to nearby lymph nodes.

The report does not mention any distant metastases, such as liver or lung metastases, which are common in stage IV cancer.

Based on the above information, I would conclude that the patient has stage III cancer, as the tumor has invaded regional lymph nodes and is relatively large.

## Answer:
{""stage"" : Stage III}"
11,"## Answer

(model generated chain of thought explanation)

To determine the AJCC stage of the cancer, I will first analyze the pathology report and identify the key features that are relevant to staging.

The pathology report indicates that the patient has invasive ductal adenocarcinoma of the pancreas, which is a type of pancreatic cancer. The tumor is well-differentiated and measures 3.7 x 3.5 x 3.5 cm. The tumor has invaded the peripancreatic soft tissues, retroperitoneal soft tissue, and the extrapancreatic common bile duct. The tumor also involves the uncinate process (retroperitoneal) margin and the common bile duct margin.

The report also indicates that the tumor has lymphatic invasion, venous invasion, and perineural invasion. The lymph nodes examined were 24, and 10 of them were involved by metastatic adenocarcinoma.

Based on these findings, I can conclude that the patient has stage III pancreatic cancer. The tumor has invaded the peripancreatic soft tissues, retroperitoneal soft tissue, and the extrapancreatic common bile duct, which is a characteristic feature of stage III pancreatic cancer. The presence of lymphatic invasion, venous invasion, and perineural invasion also supports a stage III diagnosis.

Therefore, the answer is:

{""stage"" : Stage III}"
12,"## Answer

(model generated chain of thought explanation)

The patient has pancreatic ductal adenocarcinoma, moderately differentiated, with perineural, large vessel, and lymphatic invasion. The tumor invades the duodenum, common bile duct, ampulla, and peripancreatic tissue. The carcinoma involves one of 27 lymph nodes.

The tumor size is 1.5 cm, which is considered T3, as it extends beyond the pancreas but without involvement of the celiac axis or the superior mesenteric artery. There is metastasis in a single regional lymph node, which is pN1a.

The patient's clinical history is ampullary cancer, and the preoperative diagnosis was ampullary cancer. However, the pathology report suggests that the carcinoma appears to be of pancreatic origin, based on the presence of extensive pancreatic intraepithelial neoplasia and the lack of ampullary precursors.

Considering the tumor size, lymph node involvement, and distant metastasis, the patient's stage is likely Stage III.

Therefore, the answer is - 
{""stage"" : Stage III}"
13,"## Question: Can you identify the AJCC Stage of the Cancer from the following Pathology Report?

Portal lymph node: - Reactive lymph node, no tumor (0/1).
B. Common bile duct: - Segment of bile duct, no tumor.
c. Pancreas and duodenum: - Pancreatic ductal adenocarcinoma with invasion into duodenal wall and mucosa, see parameters.
- Two of ten lymph nodes with metastatic adenocarcinoma (2/11).
PANCREAS (EXOCRINE) : Resection. Tumor Size: 2.8 x 2 x 1.7 cm. Histologic Type: Ductal adenocarcinoma. Histologic Grade: G3: poorly differentiated. Margins: All margins uninvolved by invasive carcinoma. Treatment Effect: Not applicable. Lympho-Vascular Invasion: Present. Perineural Invasion: Present. Pathologic staging (PTNM) pT3, N1, MX.

(model generated chain of thought explanation)

First, I will analyze the T stage. The tumor size is 2.8 x 2 x 1.7 cm, which is greater than 2 cm, so it falls into the T3 category. The tumor extends beyond the pancreas but without involvement of the celiac axis or the superior mesenteric artery, which is consistent with pT3.

Next, I will analyze the N stage. There are 12 lymph nodes examined, and 2 of them are involved with metastatic adenocarcinoma, which is consistent with pN1.

Finally, I will analyze the M stage. Since there is no distant metastasis mentioned in the report, the M stage is MX, which is not applicable.

(model generated chain of thought explanation)

Based on the above analysis, the patient's stage is pT3N1MX, which corresponds to Stage III.

Therefore, the answer is - 
{""stage"" : Stage III}"
14,"## Question: Can you identify the AJCC Stage of the Cancer from the following Pathology Report?

(A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV

## Model-generated chain of thought explanation:

First, I will analyze the pathology report to identify the tumor characteristics and staging information.

The pathology report indicates that the patient has an invasive moderately differentiated pancreatic ductal adenocarcinoma, with a tumor size of 4.0 x 2.7 x 2.7 cm. The tumor is classified as pT3, indicating that it extends beyond the pancreas. The lymph nodes examined were 17, and one of them was involved by tumor, indicating pN1. The report also mentions that the margins were involved by invasive tumor, indicating R1.

Based on the 7th edition TNM staging system, the patient's tumor characteristics are as follows:

* T: pT3 (tumor extends beyond the pancreas)
* N: pN1 (regional lymph node metastasis)
* M: Not applicable (no distant metastasis)

Using the AJCC staging system, I will determine the stage based on the T, N, and M categories.

For pancreatic cancer, the AJCC staging system is as follows:

* Stage I: T1-2, N0, M0
* Stage II: T1-2, N1, M0
* Stage III: T3, N0, M0 or T1-3, N1, M0
* Stage IV: Tany, N1, M1 or Tany, Nany, M1

Based on the patient's tumor characteristics, the stage is determined as follows:

* T: pT3 (tumor extends beyond the pancreas) -> Stage III
* N: pN1 (regional lymph node metastasis) -> Stage III
* M: Not applicable (no distant metastasis) -> Stage III

Therefore, the patient's AJCC stage is Stage III.

## Answer:
{""stage"" : Stage III}"
15,"## Answer

(model generated chain of thought explanation)

First, I will analyze the pathology report to identify the key features of the tumor. The tumor is an invasive adenocarcinoma of the pancreas with transmural involvement of the duodenum, invasion of the peripancreatic soft tissue, and invasion of the wall of the superior mesenteric vein. The tumor is also positive for lymph node metastases, with three out of 22 lymph nodes involved.

Next, I will evaluate the TNM stage based on the pathology report. The T stage is pT3, indicating that the tumor has invaded the wall of the superior mesenteric vein. The N stage is pN1, indicating that there is lymph node metastases. The M stage is pMX, indicating that there is no distant metastases.

Based on the TNM stage, I will determine the AJCC stage. According to the AJCC staging system, a pT3 tumor with lymph node metastases (pN1) would be classified as Stage III.

Therefore, the answer is:

{""stage"" : Stage III}"
16,"## Model-generated chain of thought explanation

First, I will identify the histological type and grade of the tumor, which is ductal adenocarcinoma, moderately differentiated (G2).

Next, I will analyze the microscopic tumor extension, which is T3, indicating that the tumor extends beyond the pancreas but without involvement of the celiac axis or the superior mesenteric artery.

The regional lymph node status is pNO, indicating that there is no regional lymph node metastasis, with 15 lymph nodes examined and none involved.

The primary tumor (pT) is T3, and the regional lymph node status (pN) is pNO. According to the AJCC staging system, a T3 tumor with no lymph node metastasis would be classified as Stage III.

Therefore, the answer is:

{""stage"" : Stage III}"
17,"## Answer

(model generated chain of thought explanation)

The patient has pancreatic cancer, specifically ductal adenocarcinoma, mucinous variant, with a histologic grade of G3 (poorly differentiated). The tumor invades the duodenal wall and has a positive margin (common bile duct margin). The patient has regional lymph node metastasis (pN1) with one peripancreatic lymph node with metastatic carcinoma present.

The tumor is T2, limited to the pancreas, more than 2 cm in greatest dimension. The patient has perineural invasion, which is a poor prognostic factor.

Based on the AJCC staging system, the patient has Stage III cancer.

Therefore, the answer is - 
{""stage"" : Stage III}"
18,"## Answer

(model generated chain of thought explanation)

The patient's pathology report indicates that the tumor is an invasive moderately-differentiated adenocarcinoma, measuring 6 x 4.5 x 3.4 cm, located in the head of the pancreas, and extending to occlude the pancreatic duct, abut the common bile duct, and show invasion into the adjacent duodenal wall. The tumor also shows extensive perineural invasion.

The report states that the tumor extends beyond the pancreas but without involvement of the celiac axis or the superior mesenteric artery, which is classified as pT3. Additionally, there is no regional lymph node metastasis (pNO) and no distant metastasis (pMO).

Based on the TNM staging system, the patient's tumor is classified as pT3N0M0, which corresponds to Stage IIA.

Therefore, the answer is - 
{""stage"" : Stage IIA}"
19,"## Model Generated Chain of Thought Explanation

The pathology report indicates that the patient has pancreatic invasive well-differentiated ductal adenocarcinoma, with the tumor measuring approximately 3.5 cm in greatest dimension. The tumor involves the common bile duct, peripancreatic fat, and tissue around the superior mesenteric vein. The tumor also shows multifocal PanIN (1-3), extensive perineural invasion, and no lymph-vascular invasion identified.

The report also states that the pancreatic distal resection margin is involved by carcinoma, and the resection margin of peripancreatic fat is less than 0.1 cm from the tumor. The posterior (uncinate) margin of the pancreas is free of tumor, with a distance of at least 1.2 cm and 0.6 cm from the PanIN. The common bile duct resection margin is also free of tumor, with a distance of 1.3 cm away.

The AJCC staging is pT4N1Mx, indicating that the tumor is T4 (invades the celiac axis or superior mesenteric artery), N1 (regional lymph node metastasis), and Mx (unknown metastasis).

Based on the pathology report, the patient has Stage III cancer, as the tumor has invaded the celiac axis or superior mesenteric artery (T4), and there is regional lymph node metastasis (N1).

## Answer
{""stage"" : Stage III}"
20,"## Question: Can you identify the AJCC Stage of the Cancer from the following Pathology Report?

ACCESSION NO. Final Diagnosis(es): (A) Lymph node, pericaval, biopsy: One lymph node negative for metastatic malignancy (0/1). (B) Lymph node, hepatic artery, blopsy: One lymph node negative for metastatic malignancy (0/1). (C) Bile duct margin, blopsy: Negative for malignancy. (D) Pancreas margin, blopsy: Negative for malignancy. (E) Antrum, duodenum, head of pancreas, common blle duct, and proximal jejunum, Whipple: Ductal adenocarcinoma, pancreatic, moderately differentiated, pT3N1MX (see synoptlo report). Synoptic Report: Specimen: Head of pancreas. Procedure: Pancreaticoduodenectomy (Whipple resection), partial pancreatectomy. Tumor Site: Pancreatic head. Tumor Size: Greatest Dimension: 2.8 cm. Additional Dimensions: 1.8 x 2,2 cm. Histologic Type: Ductal adenocarcinoma. Histologic Grade: G2: Moderately differentiated. Microscopic Tumor Extension: Tumor Invades duodenal wall. Margins: Margins uninvolved by invasive carcinoma. Lymphvascular Invasion: Present. Perineural Invasion: Present. Pathologic Staging: Primary Tumor: pT3; Tumor extends beyond the pancreas but without Involvement of the cellac axis or the superlor mesenteric artery. Regional Lymph Nodes; pN1. Regional lymph node metastasis. Number of Lymph Nodes Examined: 12. Number of Lymph Nodes Involved: 1.

Options - 
(A) Stage I 
(B) Stage II 
(C) Stage III 
(D) Stage IV

(model generated chain of thought explanation)

To determine the AJCC stage of the cancer, I will first analyze the pathologic staging information provided in the report. The primary tumor is classified as pT3, indicating that it extends beyond the pancreas but without involvement of the celiac axis or the superior mesenteric artery. This suggests that the tumor has invaded locally, but not extensively.

Next, I will examine the regional lymph node status. The report states that there"
21,"## Model-generated chain of thought explanation

The pathology report indicates that the patient has invasive moderately differentiated ductal adenocarcinoma on a background of extensive intraductal papillary mucinous neoplasm with high-grade dysplasia, forming a solid 4.6 x 2.3 x 2.0 cm mass located in the pancreatic head. The tumor extends beyond the pancreas to involve the peripancreatic soft tissue. Perineural invasion is present, and the uncinate margin tissue shows metastatic adenocarcinoma to a lymph node with soft tissue extension.

The report also states that multiple (7 of 15) regional lymph nodes are involved by metastatic adenocarcinoma, indicating lymph node metastasis. The tumor is 0.1 cm from the portal vein groove, which is a critical structure.

Based on the AJCC staging system (7th edition), the patient has pT3N1 disease, which corresponds to Stage III cancer. The T3 stage indicates that the tumor has extended beyond the pancreas to involve the peripancreatic soft tissue, and the N1 stage indicates that there is lymph node metastasis.

Therefore, the answer is:

{""stage"" : Stage III}"
22,"## Answer

(model generated chain of thought explanation)

The patient has a pancreatic head tumor with a histologic type of adenocarcinoma arising in the background of intraductal papillary mucinous neoplasm (IPMN). The tumor is well-differentiated and measures at least 4.5 cm in size. It extends into the duodenal wall and shows perineural invasion. One lymph node out of nine examined shows metastatic carcinoma.

The pTNM stage is pT3 N1, indicating that the tumor is at least 4 cm in size (T3) and has spread to one lymph node (N1).

The patient's clinical history and radiologic findings are not provided, but based on the pathology report, the tumor is considered to be invasive and has spread to one lymph node. Therefore, the AJCC stage is likely Stage III.

Therefore, the answer is - 
{""stage"" : Stage III}"
